Antiandrogen Therapy

Dec 26, 2016 by in ONCOLOGY Comments Off on Antiandrogen Therapy

Antiandrogen Therapy Bruce A. Chabner The initial attempt at treating cancer with hormone ablation was implemented by Charles Huggins at the University of Chicago in 194l, when he hypothesized that…

read more

L-Asparaginase

Dec 26, 2016 by in ONCOLOGY Comments Off on L-Asparaginase

L-Asparaginase Bruce A. Chabner Most anticancer drugs are small synthetic molecules designed to inhibit enzymes or to interact with DNA. Newer drugs may also be proteins, such as monoclonal antibodies…

read more

The Cancer Genome

Dec 26, 2016 by in ONCOLOGY Comments Off on The Cancer Genome

FIGURE 1.1 Schematic representation of the genomic and histopathological steps associated to tumor progression: from the occurrence of the initiating mutation in the founder cell to metastasis formation. It has…

read more

Cancer Metabolism

Dec 26, 2016 by in ONCOLOGY Comments Off on Cancer Metabolism

FIGURE 8.1 A graphic representation of Warburg’s experiment is shown. Most normal tissues produce lactate in large quantities only when oxygen (O2) is absent. In contrast, cancer cells tend to…

read more

Acute Leukemias

Dec 26, 2016 by in ONCOLOGY Comments Off on Acute Leukemias

SELECTED EXAMPLES OF CYTOGENETIC AND MOLECULAR ABNORMALITIES IN LEUKEMIA As with CBF fusions, the PML/RAR-α fusion protein functions as a dominant inhibitory oncogene for RAR-α–interacting proteins, including RXR-α. In addition,…

read more

Lymphomas

Dec 26, 2016 by in ONCOLOGY Comments Off on Lymphomas

FIGURE 30.1 Model for the generation of genetic lesions during lymphomagenesis. B-NHL–associated genetic lesions appear to be due to mistakes occurring during the physiologic processes of somatic hypermutation and class-switch…

read more

Bladder Cancer

Dec 26, 2016 by in ONCOLOGY Comments Off on Bladder Cancer

GENETIC CHANGES IDENTIFIED IN Ta BLADDER TUMORS CDKN2A (9p21) encodes the two cell-cycle regulators, p16 and p14ARF, which share coding region in exons 2 and 3 but have distinct exons…

read more

Endocrine Tumors

Dec 26, 2016 by in ONCOLOGY Comments Off on Endocrine Tumors

FIGURE 25.1 A schematic diagram of the genomic organization of the gene responsible for multiple endocrine neoplasia type 1 (MEN-1), including MEN-1 germline and somatic mutations. The gene contains ten…

read more

Pancreas Cancer

Dec 26, 2016 by in ONCOLOGY Comments Off on Pancreas Cancer

GENETIC PROFILE OF PANCREATIC CARCINOMA As one of the most commonly mutated genes in pancreatic cancer, Ras is an attractive target for the development of gene-specific therapies, and an understanding…

read more

Central Nervous System Tumors

Dec 26, 2016 by in ONCOLOGY Comments Off on Central Nervous System Tumors

FIGURE 28.1 Examples of grade II (panel A), grade III (anaplastic: panel B), and grade IV (glioblastoma: panels C and D) astrocytoma histopathology. Arrow in panel B shows mitotic figure…

read more
Get Clinical Tree app for offline access